HCPCS Level IIdrugActive
J9273
Inj tisotu vedotin-tftv, 1mg
BETOS: O1D
Effective: 2022-04-01
Description
Injection, tisotumab vedotin-tftv, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tivdak
Manufacturer
Pfizer Inc
HCPCS Dosage
1 MG
Billing Units
40.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.